Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Oct 22, 2026 - P1 | N=30 | Recruiting | Sponsor: City of Hope Medical Center | Trial completion date: Jun 2028 ➔ Jun 2029 | Trial primary completion date: Jun 2028 ➔ Jun 2029
Trial completion date • Trial primary completion date • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Oncology • ABL1 • EIF4G1
|